• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Biogen: Stay out of our office!


<







Yep. Same here. There is no strategizing as there is nothing to strategize. There is nothing about Aduhelm that will be moving forward. These poor souls that have been put on this drug will get a handful more free doses and even that will go away. Best for patients to wait for another therapy.
 




LOL I called to confirm a lunch and they said "we thought you were gone or we would have called you." No need to come in as docs have said they will no longer use your product.